Form 4: Candel Therapeutics Director Sells Shares in Multiple Transactions

A Candel Therapeutics director, Estuardo Aguilar-Cordova, and related trusts, sold and acquired shares in multiple transactions between December 20th and December 24th, 2024.

Summary

• Estuardo Aguilar-Cordova, a director at Candel Therapeutics, engaged in multiple transactions involving the company's stock.
• On December 20, 2024, Mr. Aguilar-Cordova directly disposed of 100,000 shares at $9 each and another 100,000 shares were disposed of indirectly through the LKA 2022 Revocable Trust at $9 each.
• On December 23, 2024, 50,000 shares were disposed of directly at $8.52 each and another 50,000 shares were disposed of indirectly through the LKA 2022 Revocable Trust at $8.52 each.
• On December 24, 2024, 50,000 shares were acquired directly at $8.82 each and 50,000 shares were disposed of indirectly through the LKA 2022 Revocable Trust at $8.82 each.
• Following these transactions, Mr. Aguilar-Cordova directly owns 273,512 shares and indirectly owns 231,443 shares through the LKA 2022 Revocable Trust.
• Additionally, Mr. Aguilar-Cordova indirectly holds 2,074,942 shares through the Estuardo Aguilar-Cordova 2020 Irrevocable Trust and his spouse, Laura K. Aguilar, indirectly holds 2,013,100 shares through the Laura K. Aguilar 2020 Irrevocable Trust.
• Mr. Aguilar-Cordova also holds 91,335 shares jointly with his spouse.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the director selling shares, which could be interpreted as a lack of confidence. However, the transactions are not large enough to cause significant alarm.

Negatives

• The director's sales of shares could be interpreted negatively by the market.

Risks

• The director's selling activity could indicate a lack of confidence in the company's future performance.
• Large sales by insiders can sometimes lead to a decrease in the stock price.

Industry Context

Insider trading activity is a common occurrence in the stock market, and these transactions are being reported as required by the SEC.

Comparison to Industry Standards

• Insider trading activity is a common occurrence in the stock market, and these transactions are being reported as required by the SEC.
• It is common for directors to buy and sell shares in their own companies, and the impact on the stock price can vary depending on the size and frequency of the transactions, as well as the overall market sentiment.

Stakeholder Impact

• Shareholders may react to the director's selling activity, potentially impacting the stock price.

Key Dates

Keywords

Candel Therapeutics, CADL, insider trading, share sales, director, Estuardo Aguilar-Cordova, LKA 2022 Revocable Trust, Laura K. Aguilar, stock transactions